Commentary · 28 Dec 2020
Research articlePublished 5 Oct 2021
Machine-Learning Driven Drug Repurposing for COVID-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The integration of machine learning methods into bioinformatics provides particular benefits in identifying how therapeutics effective in one context might have utility in an unknown clinical context or against a novel pathology. We aim to discover the underlying associations between viral proteins and antiviral therapeutics that are effective against them by employing neural network models. Using the National Center for Biotechnology Information virus protein database and the Drug Virus database, which provides a comprehensive report of Broad-Spectrum Antiviral Agents (BSAAs) and viruses they inhibit, we trained ANN models with virus protein sequences as inputs and antiviral agents deemed safe-in-humans as outputs. Model training excluded SARS-CoV-2 proteins and included only Phases II, III, IV and approved level drugs. Using sequences for SARS-CoV-2 (the coronavirus that causes COVID-19) as inputs to the trained models produces outputs of tentative safe-in-human antiviral candidates for treating COVID-19. Our results suggest multiple drug candidates, some of which complement recent findings from noteworthy clinical studies. Our in-silico approach to drug repurposing has promise in identifying new drug candidates and treatments for other viral, bacterial and parasitic infections.
Subjects
Infectious DiseasesMicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 30 Nov 2022
Interpretable Machine-Learning Model for Prediction of Convalescent COVID-19 Patients with Pulmonary Diffusing Capacity Impairment
Conference abstract · 10 Aug 2023
Targeting SARS-COV2 Main Protease Using HTVS and Simulation Analysis: A Drug Repurposing Approach against COVID-19
Mini review · 22 Jul 2021
Emergence of New Drug Discovery Paradigm using Computational and Experimental Biology: Case Study of using Repurposing Drugs for COVID-19
Editorial · 2021
Artificial intelligence in COVID-19 drug repurposing
More from this journal
The newest in Journal of Bacteriology & Parasitology.
Article · 19 Aug 2026
Echinococcal cyst of the lung at the Parasitology Laboratory of Fann Hospital: A case report
Article · 26 Feb 2026
Intestinal Parasitic Infections in Children: A Comparative Study by Type of Schooling in Keur Soce Rural Area, Senegal
Article · 19 Feb 2026
Zoonotic Parasites: Transmission Between Animals and Humans and Their Public Health Importance
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bacteriology & Parasitology
- SubjectInfectious Diseases
- SubjectMicrobiology
- BylineArticles whose byline prints “Semih Cantürk”
- BylineArticles whose byline prints “Aman Singh”
- BylineArticles whose byline prints “Jason Behrmann”
- BylineArticles whose byline prints “Patrick St-Amant”

